Animal models of obesity and diabetes mellitus

Maximilian Kleinert1,2,3,4, Christoffer Clemmensen1,2,3, Susanna M Hofmann3,5,6

  • 1Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, D-85764 Neuherberg, Germany.

Insights

Obesity and type 2 diabetes affect over a third of the global population, necessitating new treatments. This review details animal models for obesity and diabetes research to aid therapeutic development.

Area of Science:

  • Metabolic disorders
  • Pharmacology
  • Translational research

Background:

  • Over one-third of the global population is overweight or obese, increasing type 2 diabetes mellitus risk.
  • Urgent need for safer and more potent therapeutics to combat the rising pandemic of obesity and diabetes.
  • Animal models are crucial for discovering, validating, and optimizing novel therapeutics for human use.

Purpose of the Study:

  • To review currently available animal models for obesity and diabetes.
  • To highlight the advantages and limitations of each model.
  • To guide researchers in selecting appropriate models and drawing accurate conclusions for bench-to-bedside translation.

Main Methods:

  • Comprehensive literature review of established animal models for obesity and type 2 diabetes.
  • Analysis of the strengths and weaknesses of each model.
  • Consolidation of key information for researchers.

Main Results:

  • Detailed overview of various animal models used in obesity and diabetes research.
  • Identification of specific advantages and limitations for each model.
  • Emphasis on critical considerations for model selection and interpretation of results.

Conclusions:

  • Careful selection and appropriate use of animal models are essential for effective therapeutic development.
  • Understanding model-specific advantages, limitations, and caveats improves the reliability of research findings.
  • This review provides a critical resource for advancing obesity and diabetes research and drug discovery.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
270
Tonicity in Animals00:59

Tonicity in Animals

The tonicity of a solution determines if a cell gains or loses water in that solution. The tonicity depends on the permeability of the cell membrane for different solutes and the concentration of nonpenetrating solutes in the solution within and outside of the cell. If a semipermeable membrane hinders the passage of some solutes but allows water to follow its concentration gradient, water moves from the side with low osmolarity (i.e., less solute) to the side with higher osmolarity (i.e.,...
126.3K